45
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Influence of Coenzyme Q10 on Tissue Distribution of Archaeosomes, and Pegylated Archaeosomes, Administered to Mice by Oral and Intravenous Routes

, , , &
Pages 383-392 | Received 02 Jul 1999, Accepted 24 Aug 1999, Published online: 26 Jun 2009

References

  • Allen T. M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by mononuclear phagocyte system. Adv. Drug Del. Rev. 1994; 13: 285–309
  • Allen T. M., Mehra T., Hansen C., Chin Y. C. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1992; 52: 2431–2439
  • Chen H., Torchilin V., Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 1996; 13: 1378–1383
  • Choquet C. G., Patel G. B., Beveridge T. J., Sprott G. D. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Appl. Microbiol. Biotechnol. 1994; 42: 375–384
  • Choquet C. G., Patel G. B., Beveridge T. J., Sprott G. D. Formation of unilamellar liposomes from total polar lipid extracts of methanogens. Appl. Environ. Microbiol. 1992; 58: 2894–2900
  • Choudhari K. B., Labhasetwar V., Dorle A. K. Liposomes as a carrier for oral administration of insulin: effect of formulation factors. J. Microencapsul. 1994; 11: 319–325
  • Connor J., Norley N., Huang L. Biodistribution of pH-sensitive immunoliposomes. Biochim. Biophys. Acta 1986; 884: 474–481
  • Dapergolas G., Gregoriadis G. Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet 1976; ii: 842–827
  • Deshmukh D. S., Bear W. D., Brockerhoff H. Can intact liposomes be absorbed in the gut?. Life Sciences 1981; 28: 239–242
  • Ernst L., Dallmer G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995; 1271: 195–204
  • Freisleben H. J., Bormann J., Litzinger D. C., Lehr F., Rudolph P., Schatton W., Huang L. Toxicity and biodistribution of liposomes of the main phospholipid from the archaebacterium Thermoplasmaacidophilum in mice. J. Liposome Res. 1995; 5: 215–223
  • Gabizon A., Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997; 54: 15–21, Suppl. 4
  • Gregoriadis G. Targeting of drugs: implications in medicine. Lancet 1981; ii: 241–246
  • Gregoriadis G., Gursel I., Gursel M., McCormack B. Liposomes as immunological adjuvants and vaccine carriers. J. Controlled Release 1996; 41: 49–56
  • Iwanaga K., Ono S., Narioka K., Morimoto K., Kakemi M., Yamashita S., Nango M., Oku N. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int. J. Pharm. 1997; 157: 73–80
  • Lasic D. D., Martin F. J., Gabizon A., Huang S. K., Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1991; 1070: 187–192
  • Madigan M. T., Marrs B. L. Extremophiies. Scientific Amer. 1997; 276: 82–87
  • Makabi-Panzu B., Sprott G. D., Patel G. B. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein. Vaccine 1998; 16: 1504–1510
  • Micklus M. J. Liposomes enhance the oral availability of certain water-insoluble drugs. Ann. NY Acad. Sci. 1991; 618: 589–591
  • Nagata M., Yotsuyanagi T., Ikeda K. Bile salt-induced disintegration of egg phosphatidylcholine liposomes: a kinetic study based on turbidity changes. Chem. Pharm. Bull. 1990; 38: 1341–1344
  • O'Connor C. J., Wallace R. G., Iwamoto K., Taguchi T., Sunzamoto J. Bile salt damage of egg phosphatidylcholine liposomes. Biochim. Biophys. Acta 1985; 817: 95–102
  • Omri A., Beaulac C., Bouhajib M., Montplaisir S., Sharkawi M., Lagacé J. Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with. Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1994; 38: 1090–1095
  • Omri A., Ravaoarinoro M. Les liposomes: intérêts et limites en pharmacologic dans la thérapeutique des infections bacteriennes. Can. J. Clin. Pharmacol. 1998; 5: 231–241
  • Oussoren C., Zuidema J., Crommelin D. J., Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. I. Influence of the anatomical site of injection. J. Liposomes Res. 1997; 7: 85–99
  • Patel H., Ryman B. E. Oral administration of insulin by encapsulation within liposomes. FEBS Lett. 1976; 62: 60–63
  • Rathbone M. J., Tucker I. G. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv. Drug Deliv. Rev. 1993; 12: 41–60
  • Ring K., Henkel B., Valenteijn A., Gutermann R. Studies on the permeability and stability of liposomes derived from a membrane-spanning bipolar archaebacterial tetra-etherlipid. Liposomes as Drug Carriers, K. H. Schmidt, Thieme, Stuttgart 1996; 100–123
  • Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1991; 1062: 77–82
  • Sprott G. D., Tolson D. L., Patel G. B. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 1997; 154: 17–22
  • Sprott G. D. Structures of archaeobacterial membrane lipids. J. Bioenerget. Biomembr. 1992; 24: 555–566
  • Sprott G. D., Dicaire C. J., Fleming L. P., Patel G. B. Stability of liposomes prepared from archaeobacterial lipids and phosphatidylcholine mixtures. Cells and Materials 1996; 6: 143–155
  • Takada M., Yuzuriha T., Katayama K., Iwamoto K., Sunamoto J. Increased lung uptake of liposomes coated with polysaccharides. Biochim. Biophys. Acta 1984; 802: 237–244
  • Woodley J. F. Liposomes for oral administration of drugs. Crit. Rev. Ther. Drug Carrier Syst. 1986; 2: 1–70
  • Zhou S. Y., Pao L. H., Weiner N., Fleisher D., Zimmermann E. Targeting drugs to the intestine with oral liposomes. Proc. Intl. Symp. Control. Rel. Bioact. Mater. 1997; 24: 855–856

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.